NDC 62856-410

DAYVIGO

Lemborexant

DAYVIGO is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Eisai Inc.. The primary component is Lemborexant.

Product ID62856-410_08ce5d4f-11e3-42c9-9e5a-801a3afca000
NDC62856-410
Product TypeHuman Prescription Drug
Proprietary NameDAYVIGO
Generic NameLemborexant
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2020-04-07
Marketing CategoryNDA / NDA
Application NumberNDA212028
Labeler NameEisai Inc.
Substance NameLEMBOREXANT
Active Ingredient Strength10 mg/1
DEA ScheduleCIV
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 62856-410-30

30 TABLET, FILM COATED in 1 BOTTLE (62856-410-30)
Marketing Start Date2020-04-07
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 62856-410-90 [62856041090]

DAYVIGO TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA212028
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-04-07

NDC 62856-410-30 [62856041030]

DAYVIGO TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA212028
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2020-04-07

Drug Details

Active Ingredients

IngredientStrength
LEMBOREXANT10 mg/1

OpenFDA Data

SPL SET ID:7074cb65-77b3-45d2-8e8d-da8dc0f70bfd
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 2272414
  • 2272408
  • 2288425
  • 2288427
  • UPC Code
  • 0362856410908
  • 0362856405904
  • 0362856405300
  • 0362856410304
  • NDC Crossover Matching brand name "DAYVIGO" or generic name "Lemborexant"

    NDCBrand NameGeneric Name
    62856-405DAYVIGOlemborexant
    62856-410DAYVIGOlemborexant
    62856-455DAYVIGOlemborexant

    Trademark Results [DAYVIGO]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    DAYVIGO
    DAYVIGO
    88655847 not registered Live/Pending
    Eisai R&D Management Co., Ltd.
    2019-10-15
    DAYVIGO
    DAYVIGO
    88058574 not registered Live/Pending
    Eisai R&D Management Co., Ltd.
    2018-07-30

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.